GLPG

Galapagos Nv

• TipRanks·04/01 08:18

  UBS Reaffirms Their Hold Rating on Galapagos (0JXZ)

• TipRanks·04/01 05:56

  Barclays Sticks to Its Sell Rating for Galapagos (0JXZ)

• TipRanks·03/31 13:01

  Galapagos Strikes New Gilead Deal to Co-Develop Gamgertamig and Unlock $500 Million for Strategic Moves

• TipRanks·03/31 12:55

  Bernstein Sticks to Their Hold Rating for Galapagos (0JXZ)

• TipRanks·03/31 09:30

  Galapagos, Gilead enter pact to collaborate on T cell engager therapies

• NASDAQ·03/31 06:24

  Galapagos Enters Framework Agreement With Gilead In Connection With Ouro Deal

• Seeking Alpha·03/31 05:48

  Galapagos NV, Gilead Sciences strike deal tied to Ouro Medicines acquisition

• Benzinga·03/31 05:39

  Galapagos And Gilead Collaborate On Ouro's $1.675B Acquisition, Retaining $500M Cash With Up To $150M Return To Shareholders

• Reuters·03/31 05:33

  Galapagos, Gilead sign deal to collaborate on Ouro’s autoimmune T-cell engager program

• Reuters·03/31 05:32

  Galapagos, Gilead sign deal tied to Ouro acquisition for T cell engager program

• Reuters·03/31 05:30

  GALAPAGOS NV - MAY SPEND $500 MLN INDEPENDENTLY, INCLUDING UP TO $150 MLN FOR SHARE REPURCHASES OR DIVIDENDS

• Reuters·03/31 05:30

  GALAPAGOS NV - TO BUY OURO'S OPERATIONAL ASSETS INCLUDING FACILITIES AND PERSONNEL

• TipRanks·03/30 13:07

  Galapagos Files 2025 Annual Report and Calls April 28 Meetings on Rebranding and Share Buyback

• Reuters·03/26 20:43

  Galapagos announces annual and extraordinary shareholder meetings; proxy and voting-by-letter forms posted online

• Reuters·03/26 20:42

  Galapagos shareholders vote April 28, 2026; authorized capital renewal rises to 20% of share capital